NEW YORK (GenomeWeb News) — Biosite today disclosed that it “currently intends” to accept Inverness Medical Innovations’ bid to acquire it, and plans to terminate an earlier offer made by Beckman Coulter.
 
In the latest, and what appears to be final, twist of the ongoing battle for Biosite, the company said that a binding offer it recently received from Inverness is “superior” to Beckman Coulter’s bid as defined in the existing merger agreement between Beckman Coulter and Biosite.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.